Answers are grounded in this paper and cite their sources.
Purpose To characterize additional retinal oxidative, structural and functional outcomes in a previously published cohort of streptozotocin-induced diabetic rats.–- Street E 42, Redenção, Vitória de Santo Antão, PE, 55,612–050, Brazil.– Methods Fifty male Wistar rats were allocated to control, untreated diabetic, concurrent melatonin, delayed melatonin or insulin-treated groups (10 per group). Melatonin was administered subcutaneously at 10 mg/kg for 20 days, starting at diabetes induction or after confirmation. Retinal superoxide production, NADPH oxidase activity, histology and microvascular morphology were assessed. Morphometry used five slides from five animals per group (one slide per animal; n = 5). Pancreatic glutathione and lipid peroxidation were additional tissue-specific measures. Electroretinography was described qualitatively because numerical results were unavailable. Previously published glycemic and insulin results are not reproduced. Results Both melatonin groups showed lower retinal oxidative measures and more favorable morphometric outcomes than untreated diabetic animals. The reported comparisons did not identify significant differences between melatonin schedules for these endpoints. Pancreatic oxidative measures were also more favorable in treated animals. Descriptive electrophysiological observations did not establish functional recovery. Conclusion These findings extend the oxidative and morphological characterization of melatonin-associated retinal changes in a shared cohort. Neither schedule showed clear superiority and functional benefits or reversal of established retinopathy remain unproven.
No takes yet. Share an insight, caveat, or question.
Melo et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: